Loading interface...

Temotrust 20 mg Capsule

Manufactured byPanacea Biotec Ltd.
ContainsTemozolomide
Description

Temotrust 20 mg Capsule is an anticancer agent used in the treatment of certain types of brain cancers. This medicine should be used with caution in patients with a known history of hepatic and renal impairment. It is not recommended for use in children under 3 years of age.

Side effects

Major & minor side effects for Temotrust 20 mg Capsule

  • Nausea and Vomiting
  • Diarrhea
  • Loss of appetite
  • Headache
  • Dizziness
  • Hair loss
  • Insomnia
  • Anxiety
  • Confusion
  • Drowsiness
  • Mental depression
  • Runny Nose

Uses of Temotrust 20 mg Capsule

What is it prescribed for?

  • Anaplastic Astrocytoma
  • Glioblastoma Multiforme
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required for this medicine to show its effect is not clinically established.
  • How long do the effects of this medicine last?
    The time until which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women due to the increased risk of fetal harm.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women due to the increased risk of severe adverse effects in the breastfed baby.

Allergy

This medicine is not recommended for use in patients with a known allergy to dacarbazine, temozolomide or any other ingredients present along with it.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women due to the increased risk of fetal harm.

Breast-feeding

This medicine is not recommended for use in breastfeeding women due to the increased risk of severe adverse effects in the breastfed baby.
General warnings

Hepatotoxicity

Temotrust 20 mg Capsule should be used with caution in patients with a history of liver disease due to the increased risk of severe adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Blood cell count

This medicine should be used with caution due to the increased risk of very low blood cell counts. Close monitoring of blood cell counts is necessary during treatment with this medicine. Appropriate dose adjustments or discontinuation of therapy may be required based on the clinical condition.

Impaired kidney function

Temotrust 20 mg Capsule should be used with caution in patients with a history of kidney disease due to the increased risk of severe adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Missed Dose

If you miss a dose of Temotrust 20 mg Capsule or a scheduled appointment for a dose of Temotrust 20 mg Capsule, call your doctor immediately for further instructions. Do not use extra medicine to make up for a missed dose.

Overdose

Oral: Seek emergency medical treatment or contact the doctor immediately in case of a suspected overdose. Injection: Since this medicine is administered by a qualified healthcare professional in the clinical or hospital setting, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose with this medicine is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Clozapine

Fluorouracil

Ganciclovir

Busulfan

Disease interactions

Myelosuppression

This medicine should be used with caution due to the increased risk of bone marrow suppression and decreased blood cell counts. Close monitoring of blood cell counts is necessary during treatment with this medicine. Appropriate dose adjustments or discontinuation of therapy may be required based on the clinical condition.

Hepatic impairment

Temotrust 20 mg Capsule should be used with caution in patients with a history of liver disease and active liver disease due to the increased risk of severe adverse effects. Report any unusual symptoms to the doctor immediately. Close monitoring of liver function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.

Renal Dysfunction

Temotrust 20 mg Capsule should be used with caution in patients with a history of kidney disease and active kidney disease due to the increased risk of severe adverse effects. Report any unusual symptoms to the doctor immediately. You may require a dose adjustment and more frequent kidney function monitoring to safely use this medicine. Replacement with a suitable alternative may be required based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This medicine is given in multiple cycles. It is important to receive every scheduled dose and make a note of the next scheduled dose. Carefully follow all the instructions given by your doctor. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor. Report any unusual symptoms to your doctor immediately. Close monitoring of blood cells counts is necessary during treatment with this medicine.
Miscelleneous

To be taken on an empty stomach

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Temotrust 20 mg Capsule blocks the cancer cells from multiplying and stops their growth.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Alkylating agents

Schedule

Schedule H

[Internet]. 2017 [cited 1 September 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/7027

DailyMed - Temozolomide capsule [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 1 September 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d599ccf-8e63-4ff1-aa52-4809744ea97a

Prescribing medicines in pregnancy database [Internet]. Therapeutic Goods Administration (TGA). 2017 [cited 1 September 2017]. Available from:

https://www.tga.gov.au/prescribing-medicines-pregnancy-database

Temozolomide - DrugBank [Internet]. Drugbank.ca. 2017 [cited 1 September 2017]. Available from:

https://www.drugbank.ca/drugs/DB00853

Temozolomide: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 1 September 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a601250.html
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 19 Sep 2017

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.